Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Cancer Research

• Publication date

  1999-06-15

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10383167
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Catalog of Human Cytokeratins: Patterns of Expression in Normal Epithelia, Tumors and Cultured Cells Review

  2004cited by this paper
• Human and mouse proteomic databases: novel resources in the protein universe

  1998cited by this paper
• Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation.

  1997cited by this paper
• Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry

  1996cited by this paper
• Bladder squamous cell carcinomas express psoriasin and externalize it to the urine.

  1996cited by this paper
• The human keratinocyte two‐dimensional gel protein database (update 1995): Mapping components of signal transduction pathways

  1995cited by this paper
• High-Resolution Two-Dimensional Gel Electrophoresis of Proteins: Isoelectric Focusing and Nonequilibrium pH Gradient Electrophoresis (NEPHGE)

  1994cited by this paper
• Identification of transformation sensitive proteins recorded in human two‐dimensional gel protein databases by mass spectrometric peptide mapping alone and in combination with microsequencing

  1994cited by this paper
• Urinary bladder carcinoma with a neoplastic squamous component: a mapping study of 31 cases

  1992cited by this paper
• Protein-electroblotting and -microsequencing strategies in generating protein data bases from two-dimensional gels.

  1989cited by this paper
• Characterization of a monoclonal antibody (BG3C8) that reacts with basal cells of stratified epithelia

  1987cited by this paper
• Tumors of the Kidney and Urinary Tract: Color Atlas and Textbook

  1985cited by this paper
• High resolution two-dimensional electrophoresis of proteins.

  1975cited by this paper
• “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin

  1953cited by this paper

• Proteomic analysis of IgM antigens from mammary tissue under pre- and post-cancer conditions using the MMTV-PyVT mouse model

  2022cites this paper
• Cancer Omics: A Special Issue to Highlight Where We Are Heading

  2018cites this paper
• Large-Scale SRM Screen of Urothelial Bladder Cancer Candidate Biomarkers in Urine.

  2017cites this paper
• Clinical proteomics in cancer: Where we are.

  2016cites this paper
• Proteomic profiles and ultrastructure of regenerating protoplast of Bryopsis plumosa (Chlorophyta)

  2016cites this paper
• 51 – Biology of Lung Cancer

  2016cites this paper
• Proteome research in urothelial carcinoma

  2015cites this paper
• Clinical Proteomics

  2015cites this paper
• Novel markers of squamous differentiation in the urinary bladder.

  2013cites this paper
• Biomarkers for detection and surveillance of bladder cancer.

  2013cites this paper
• Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract.

  2013cites this paper
• The impact of squamous and glandular differentiation on survival after radical cystectomy for urothelial carcinoma.

  2012cites this paper
• Comparative Proteomics: An Approach to Elucidating the Function of a Novel Gene Called BRE

  2012cites this paper
• Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy.

  2011cites this paper
• Proteomics : Opportunities and Challenges

  2011cites this paper
• Biology of Non–Small Cell Lung Cancer

  2010cites this paper
• Transgelin as a suppressor is associated with poor prognosis in colorectal carcinoma patients

  2009cites this paper
• Overexpression of heat shock protein 27 in squamous cell carcinoma of the uterine cervix: a proteomic analysis using archival formalin-fixed, paraffin-embedded tissues.

  2009cites this paper
• Prediction of Muscle-invasive Bladder Cancer Using Urinary Proteomics

  2009cites this paper
• Challenges of using mass spectrometry as a bladder cancer biomarker discovery platform

  2008cites this paper
• Contribution of proteomics to the study of the role of cytokeratins in disease and physiopathology

  2008influential citation
• Solid tumor proteome and phosphoproteome analysis by high resolution mass spectrometry.

  2008cites this paper
• Proteomic‐based approach for biomarkers discovery in early detection of invasive urothelial carcinoma

  2008cites this paper
• Analysis of human plasma proteins: a focus on sample collection and separation using free-flow electrophoresis

  2008cites this paper
• Proteomic strategies in bladder cancer: From tissue to fluid and back

  2008cites this paper
• [Theoretical foundations of protein chips and their possible use in medical research and diagnostics].

  2007cites this paper
• Reticulitermes flavipes (Isoptera: Rhinotermitidae) proteomics

  2007cites this paper
• Differential proteomic analysis of human colorectal carcinoma cell lines metastasis-associated proteins

  2007cites this paper
• The effects of weaning stress on the serum protein profile of calves : a proteomic analysis

  2007cites this paper
• Searching urinary tumor markers for bladder cancer using a two-dimensional differential gel electrophoresis (2D-DIGE) approach.

  2007cites this paper
• Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia

  2007cites this paper
• An array of possibilities in cancer research using cytokine antibody arrays

  2007cites this paper
• Simultaneous proteomic and genomic analysis of primary Ta urothelial cell carcinomas for the prediction of tumor recurrence.

  2007cites this paper
• Yüzeyel Mesane Tümörlerinde Tanısal ve Prognostik Yeni Belirleyiciler

  2006cites this paper
• Comparative Metabolomics of Breast Cancer

  2006cites this paper
• Novel Diagnostic Markers and Prognosticators in Superficıal Bladder Cancer

  2006cites this paper
• Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry

  2006cites this paper
• The detection of potential drug resistance markers using proteomic technologies

  2006cites this paper
• Fine needle aspiration cytology: diagnostic principles and dilemmas

  2006cites this paper
• Molecular Biomarkers for Cancer Detection in Blood and Bodily Fluids

  2006cites this paper
• Automation of biochip array technology for quality results

  2005cites this paper
• Revealing urologic diseases by proteomic techniques.

  2005cites this paper
• Chapter 16 Clinical cancer proteomics

  2005cites this paper
• Proteomics: A New Emerging Area of Biotechnology

  2005cites this paper
• Clinical cancer proteomics: promises and pitfalls.

  2005cites this paper
• Proteomics: the basic overview.

  2005cites this paper
• Chapter 4 Two-dimensional gel electrophoresis: the state of the art

  2005cites this paper
• Transcriptomic and proteomic approaches to the discovery of new markers of pathology

  2005cites this paper
• Identification and relative quantification of membrane proteins by surface biotinylation and two‐dimensional peptide mapping

  2005cites this paper
• Detection of peroxidase activity in two-dimensional gel electrophoresis

  2005cites this paper
• Identification and validation of metastasis-associated proteins in head and neck cancer cell lines by two-dimensional electrophoresis and mass spectrometry

  2004cites this paper
• Two-dimensional electrophoretic protein profile analysis following exposure of human uroepithelial cells to occupational bladder carcinogens.

  2004cites this paper
• Molecular oncology in the post-genomic era: the challenge of proteomics.

  2004cites this paper
• Metabolic profiles of cancer cells

  2004cites this paper
• Applying proteomic methodologies to analyze the effect of hexamethylene bisacetamide (HMBA) on proliferation and differentiation of human gastric carcinoma BGC-823 cells.

  2004cites this paper
• Impact of proteomics on bladder cancer research.

  2004cites this paper
• Recent advances in bladder cancer diagnostics.

  2004cites this paper
• Proteomics: the Basic Overview Protein Identification by Mass Spectrometry 20 Hybrid Instruments 26 Bioinformatics for the Identification of Proteins Based on Ms/ms 46 Current Challenges in Proteomics 49 Classical Proteomics 49 Gel-free Analysis: an Alternative Differential Display 50 Fourier Transo

  2004cites this paper
• Molecular markers for predicting recurrence, progression and outcomes of bladder cancer (do the poster boys need new posters?)

  2004cites this paper
• Methodological advances in the discovery of protein and peptide disease markers.

  2004cites this paper
• The use of proteomics for the assessment of clinical samples in research.

  2004cites this paper
• Proteomic studies in urological malignancies.

  2004cites this paper
• Proteomics-Based Approaches

  2004cites this paper
• Proteomics in Pancreatic Disease

  2004cites this paper
• Proteomics in translational cancer research: toward an integrated approach.

  2003cites this paper
• Protein Profiling of the Human Epidermis from the Elderly Reveals Up-regulation of a Signature of Interferon-γ-induced Polypeptides That Includes Manganese-superoxide Dismutase and the p85β Subunit of Phosphatidylinositol 3-Kinase*

  2003cites this paper
• Proteomics in the postgenomic age.

  2003cites this paper
• Approaches to proteomic analysis of human tumors.

  2003cites this paper
• The need to embrace molecular profiling of tumor cells in prostate and bladder cancer.

  2003cites this paper
• Early detection: Proteomic applications for the early detection of cancer

  2003cites this paper
• Proteomics in biomarker discovery and drug development

  2003influential citation
• Integrating Proteomic and Functional Genomic Technologies in Discovery-driven Translational Breast Cancer Research*

  2003cites this paper
• Gene expression profiling of inflammatory bladder disorders

  2003cites this paper
• Practical Approaches to Protein Microarrays

  2003cites this paper
• Immunochemical studies of antigenic 
lymphoma‐associated proteins

  2002cites this paper
• Design of proteome‐based studies in combination with serology for the identification of biomarkers and novel targets

  2002cites this paper
• Proteomics in Urological Cancer Research

  2002cites this paper
• Proteomic Strategies to Reveal Tumor Heterogeneity among Urothelial Papillomas *

  2002cites this paper
• Proteomics and its impact upon biomedical science

  2002cites this paper
• Human proteomic databases: a powerful resource for functional genomics in health and disease.

  2002cites this paper
• Applied genome research in the field of human vaccines.

  2001cites this paper
• Proteomics for studying cancer cells and the development of chemoresistance

  2001cites this paper
• PROTEOMICS IN HUMAN DISEASE: AWARENESS OF NEW BIOMEDICAL OPPORTUNITIES

  2001cites this paper
• Quantifying Viral Propagation in Vitro: Toward a Method for Characterization of Complex Phenotypes

  2001cites this paper
• Detection of multiple proteins in an antibody-based protein microarray system.

  2001cites this paper
• NEWAPPROACHES TO THEUNDERSTANDING OFTHEMOLECULARBASISOFORALCANCER

  2001cites this paper
• New approaches to the understanding of the molecular basis of oral cancer.

  2001cites this paper
• Proteomic approaches to biomarker discovery in prostate and bladder cancers

  2001cites this paper
• Two‐Dimensional Gel Electrophoresis and Mass Spectrometry for Proteomic Studies: State‐of‐the‐Art

  2001cites this paper
• IBC – Proteomics, 1–2 March 2000, Basel Hilton, Switzerland

  2001cites this paper
• Spot the differences: proteomics in cancer research.

  2001cites this paper
• Proteomics: new perspectives, new biomedical opportunities

  2000cites this paper
• Use of Markers in Defining Urothelial Premalignant and Malignant Conditions

  2000cites this paper
• Bladder squamous cell carcinoma biomarkers derived from proteomics

  2000cites this paper
• Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics

  2000cites this paper
• Proteomics: applications in basic and applied biology.

  2000cites this paper
• Mass spectrometric analysis of proteins.

  2000cites this paper
• Molecular pathology and future developments.

  1999cites this paper
• Proteomic Strategies in Bladder Cancer

  1999cites this paper